The trend today, encouraged by major
funding sources like the National Institutes of Health (NIH), is to
support basic, interdisciplinary science that leads to clinical
applications, says Dr. Britigan.
Under what he describes as his delegating
and interactive leadership style, Dr. Britigan says the department will
move into a new growth phase, developing more cross-disciplinary
programs that involve varied fields such as molecular and cell biology,
genetics, physiology, immunology, microbiology ,biochemistry,
epidemiology and outcomes research- "and translating that research to
important advances in patient care."
Dr. Britigan became chairman June 2, following the retirement of Robert Luke, MD, who had led the department since 1988.
Dr. Britigan was formerly professor of
internal medicine and radiation oncology and headed the Division of
Infectious Diseases at the University of Iowa. He earned his MD from
the University of Southern California and completed his internal
medicine training at Rhode Island Hospital. He did subspecialty
training in infectious diseases at the University of North Carolina at